Bristol aripiprazole
Executive Summary
Trade name for antipsychotic is expected to be Abilitat. Bristol filed for the trademark in June 1999, before licensing aripiprazole from Otsuka. The trademark issued June 20 gives Bristol considerable leeway, covering products "for the treatment of cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases"